RBI Aktienanleihe OMV 24.09.2025/ AT0000A3C598 /
1/24/2025 9:15:51 AM | Chg.+0.290 | Bid9:25:18 AM | Ask9:25:18 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
105.720EUR | +0.28% | 105.530 Bid Size: 50,000 |
105.780 Ask Size: 50,000 |
OMV AG | 45.00 EUR | 9/24/2025 | Call |
GlobeNewswire
3/26/2024
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16/2024
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center